Compare ArcelorMittal SA (MT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs Zimmer Biomet Holdings Inc — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: ArcelorMittal SA is far larger — about 2.9× Zimmer Biomet Holdings Inc's market cap, and Zimmer Biomet Holdings Inc pays the higher dividend (1.07%). Which is the better fit depends on your goals.
| MT | ZBH | |
|---|---|---|
Market Cap | $50.01B | $17.36B |
Sector | Basic Materials | Health |
52-Week High | $71.65 | $107.71 |
52-Week Low | $30.39 | $79.58 |
Enterprise Value | $59.33B | $24.40B |
Dividend Yield | 0.91% | 1.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ArcelorMittal (MT) trades at $65.80, down 0.98% today, with a bullish technical outlook supported by moving averages. The stock shows strong earnings momentum, beating estimates for three consecutive quarters, and maintains a reasonable valuation with a P/E of 17.24 and P/S of 0.81. Recent corporate developments include ongoing share buybacks and a strategic AI collaboration with AWS to enhance operational efficiency.
The outlook for MT is cautiously optimistic, driven by earnings strength and cost initiatives, but faces risks from cyclical steel demand and high capital expenditures. Analyst sentiment is mixed with 50% buy ratings, suggesting potential upside if operational improvements continue, though investors should monitor global economic conditions impacting steel prices.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
